Cambridge Nutraceuticals builds brand portfolio with acquisition of GP Nutrition
Cambridge Nutraceuticals, the parent company of science-backed nutritional food supplement brands, FutureYou Cambridge and Prime Fifty, has expanded its brand portfolio with the acquisition of GP Nutrition. GP Nutrition was founded by leading nutritionist and double Sunday Times bestselling author, Gabriela Peacock.
Stemnovate seeks volunteers as it creates children’s rare disease platform in battle against mitochondrial conditions
Biotech company Stemnovate is accelerating its research into rare mitochondrial diseases in children that severely impact the liver, heart and brain.
Sano Genetics offers free genetic MND testing in UK via new support platform
Sano Genetics will offer over 200 cost-free tests to individuals with a family history or a diagnosis of motor neurone disease (MND).
Albotherm and Lumiforte to collaborate on a seasonal, heat-activated shade coating
Albotherm Ltd, a UK based advanced materials startup, and leading Dutch horticultural coatings manufacturer Lumiforte announce their partnership to explore the integration of Lumiforte’s removable greenhouse coatings system with Albotherm’s patent pending, heat-activated shading technology.
Psyomics secures £4M to revolutionise mental health assessment with AI
Psyomics, a UK-based mental health technology company, has secured £4 million in fresh funding. Parkwalk Advisors (which invested in adsilico and Oxford Endovascular) the UK’s most active investor in university spinouts, led the funding round by investing a further £3.5 million.
Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows
Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto-Cellect®PLUS. In conjunction with the Company’s Cyto-Mine® platform, the new assay provides a streamlined method to measure antibody production in single cells by rapidly detecting secreted human IgG, enabling the identification and selection of cells with the highest productivity for more efficient cell line development.
DefiniGEN and Atelerix prevent freezing damage in cell models
DefiniGEN Ltd., and Atelerix Ltd. have successfully shipped in vitro liver models from the UK to the US without freezing them thus preventing cell damage and loss-of function.
Gloucestershire firm captures the power of Wild Hydrogen
WILD Hydrogen, based in Hardwicke, has developed a method of producing affordable, carbon-negative hydrogen that could be used to power trucks, ships and even airplanes.
Featurespace and Pay.UK pilot takes scam-busting tech to new heights
A new pilot undertaken by Cambridge crime busting company Featurespace and Pay.UK demonstrated unprecedented capability to save customers under attack from online fraudsters millions of pounds.
MP’s ieso Digital Health visit is nod to venture capital success story
Lucy Frazer, the MP for South East Cambridgeshire and Secretary for Culture, Media and Sport, praised ieso Digital Health on a visit to the company’s premises at The Jeffreys Building on Cowley Road.
